ISDA

Entry Detail

PDB ID:

5M0E

Keywords:

HYDROLASE

Title:

Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors

Biological Source:

Source Organism:

Rattus norvegicus

Host Organism:

Homo sapiens

PDB Version:

Deposition Date:

2016-10-04

Release Date:

2017-08-16

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.95 Å

R-Value Free:

0.22

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Ectonucleotide pyrophosphatase/phosphodiesterase family member 2
Mutations:N410A, L581F, R591T, N806A
Chain IDs:A
Chain Length:827
Number of Molecules:1
Biological Source:Rattus norvegicus

UniProt ID:Q64610 Pfam ID:PF01033, PF01663, PF01223 EC:3.1.4.39

Ligand Molecules

5JK

7CR

GOL

IOD

SCN

Primary Citation

Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.

Keune, W.J, Potjewyd, F, Heidebrecht, T, Salgado-Polo, F, Macdonald, S.J, Chelvarajan, L, Abdel Latif, A, Soman, S, Morris, A.J, Watson, A.J, Jamieson, C, Perrakis, A.Show

J. Med. Chem. 60 2006 2017 (2017)

PMID: 28165241 DOI: 10.1021/acs.jmedchem.6b01743

Abstact

Autotaxin produces the bioactive lipid lysophosphatidic acid (LPA) and is a drug target of considerable interest for numerous pathologies. We report the expedient, structure-guided evolution of weak physiological allosteric inhibitors (bile salts) into potent competitive Autotaxin inhibitors that do not interact with the catalytic site. Functional data confirms that our lead compound attenuates LPA mediated signaling in cells and reduces LPA synthesis in vivo, providing a promising natural product derived scaffold for drug discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures